PFPG
GSK icon

Pinnacle Financial Partners (Georgia)’s GSK GSK Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.32M Sell
139,689
-941
-0.7% -$49.8K 0.05% 261
2026
Q1 		$7.76M Sell
140,630
-1,327
-0.9% -$71.9K 0.06% 238
2025
Q4 		$6.96M Buy
+141,957
New +$6.62M 0.05% 249

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s GSK Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) reduced its GSK (GSK) stake by 0.67% in Q2 2026, selling an estimated $49.8K and leaving 139,689 shares worth $7.32M. The position accounts for 0.05% of the portfolio, ranked #261.

Pinnacle Financial Partners (Georgia) first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $7.76M in Q1 2026. 1,038 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 139,689 shares of GSK worth $7.32M as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) sold 941 GSK shares in Q2 2026, an estimated $49.8K.
  • GSK made up 0.05% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #261 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Financial Partners (Georgia)'s GSK position peaked at $7.76M in Q1 2026.
  • 1,038 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.